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Introduction
Patients with severe mitral valve (MV) disease can develop alter-
ations in left atrial (LA) geometry and function, a process known as 
LA remodeling. LA remodeling refers to a time-dependent adaptive 
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regulation of cardiac myocytes to maintain homeostasis against 
external stressors such as valvular disease.1) LA remodeling is often 
accompanied by a change in LA function with a progressive increase 
in interstitial fibrosis. Increased LA size and change in LA function 
with fibrosis are associated with subsequent development of atrial 
fibrillation (AF), stroke, acute myocardial infarction, congestive he-
art failure, as well as cardiac and all-cause mortality.2-5) However, LA 
remodeling is reversible, and MV surgery can relieve LA pressure and 
volume overload, thereby reducing LA size and improving LA func-
tion; i.e., LA reverse remodeling.6)7) The direct impact of reversing LA 
remodeling on cardiovascular outcomes remains to be seen, but the 
evidence, at least indirectly, suggests that the risk of certain out-
comes, such as AF and stroke, can be significantly reduced. If the 
factors associated with LA fibrosis and reverse remodeling can be 
determined, especially by non-invasive methods, they could be valu-
able for clinical evaluation, risk stratification, and earlier therapeu-
tic intervention for patients with MV disease. This study was con-
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ducted to determine predictors for the degree of LA fibrosis as de-
termined by histopathology and reverse remodeling after MV sur-
gery using speckle tracking echocardiography. 
Subjects and Methods
Patients and study protocol
From May 2007 to July 2008, 53 cases were enrolled. Exclusion 
criteria included previous MV replacement or repair, concomitant se-
vere aortic valve disease, congenital heart disease, coronary artery 
disease, chronic liver disease, chronic renal disease, uncontrolled thy-
roid disease, poor echocardiographic window, and insufficient myo-
cardial tissue. Among them, three cases were excluded due to poor 
echo image qualities (n=2) and insufficient tissue to be analyzed 
(n=1). Finally, 50 patients (mean age, 56±12 years) scheduled for 
MV surgery due to severe MV stenosis {mitral stenosis (MS), n=28} 
or regurgitation {mitral regurgitation (MR), n=22} with primary cau-
ses of rheumatic disease (n=32) and degenerative disease (n=18) 
were studied. All patients provided written informed consent, and 
the institutional review board at the University Health System ap-
proved this study. Atrial tissue samples were obtained from the LA 
free wall near the interatrial septum during MV surgery, were quickly 
frozen in liquid nitrogen, and were stored at -80°C until use. Con-
ventional transthoracic echocardiography and two-dimensional 
(2D) speckle tracking echocardiography were performed preopera-
tively on the patients. All the patients underwent repeated echo-
cardiography including LA volume measurements within 30 days 
after surgery and LA volume measurements at 1.4±0.5 years after 
surgery were taken for 39 patients. 
Conventional transthoracic echocardiography
Each patient underwent a complete standard transthoracic echo-
cardiography study using a Vivid 7 apparatus (GE Medical Systems, 
Milwaukee, WI, USA) with a 2.5-MHz phased-array transducer. Left 
ventricular (LV) dimensions and LV ejection fraction were measured 
as recommended by the American Society of Echocardiography 
guidelines.8) According to these guidelines, LA maximal volume was 
measured using the prolate ellipsoidal method8)9) at the point of 
MV opening when the LA size was maximum and LA minimal vol-
ume was measured at the point of MV closure when LA size was mi-
nimum. LA reservoir fraction was calculated as (LA maximal volume-
LA minimal volume)÷LA minimal volume.10) We estimated the degree 
of LA reverse remodeling as the percent change in LA maximal vol-
ume index (LAVImax) after MV surgery. In the case of LA volume in-
crease after surgery, we used the negative value of percent LA vol-
ume reduction. All LA volume values were obtained as the mean of 
three consecutive beats and were adjusted for body surface area, 
due to the influence of body size on LA volume. 
Speckle tracking echocardiography
For the LV speckle tracking analysis, apical four- and two-cham-
ber view images were obtained using conventional gray scale echo-
cardiography (Vivid 7; GE Medical Systems). For the LA speckle track-
ing analysis, LA-focused images in apical four-chamber and two-
chamber views were obtained. Two consecutive heart cycles were re-
corded and averaged, and five consecutive heart cycles were av-
eraged for AF patients. A minimum frame rate of 40 frames per se-
cond was required for the reliable operation of this program. Recor-
dings were processed using acoustic-tracking software (EchoPAC 
v8.0; GE Medical Systems), allowing offline, semi-automated analy-
sis of speckle-based strain.11) For 2D speckle tracking strain analy-
sis, a line was manually drawn along the LA endocardial border of 
the apical four- and two-chamber views after contraction, when the 
LA was at its minimum volume, using the point-and-click approach. 
The software then automatically generated additional lines near 
the atrial epicardium and mid-myocardial line, with the narrowest 
region of interest (ROI). The ROI then included the entire LA myo-
cardial wall, and a click feature increased or decreased the widths 
between endocardial and epicardial line for thicker or thinner walls, 
respectively. The software generated strain curves for each atrial 
segment. A total of 12 segments were analyzed for each patient for 
whom the imaging results were of adequate quality. To trace the 
ROI in the discontinuity of the LA wall corresponding to the pulmo-
nary veins and LA appendage, the directions of the LA endocardial 
and epicardial surfaces at the junction with these structures were 
extrapolated. The peak atrial longitudinal global strain was gener-
ated using the peaks of entire LA segments and the mean values 
obtained in the four- and two-chamber views (Fig. 1). 
Assessments of reproducibility
The reproducibility of 2D speckle tracking strain measurements 
were assessed using the data of 10 randomly selected patients. Two 
independent investigators analyzed patient data to obtain inter-
observer variability using Bland-Altman analysis and 95% limits of 
the equal-tailed Jeffrey’s prior interval.12) The same investigators an-
alyzed the same patient data to assess intra-observer variability. 
Histology 
To measure the fibrosis area, tissue was cleaned with phosphate 
buffered saline (Gibco BRL, Carlsbad, CA, USA) to remove the blood. 
Samples were fixed in 10% formalin solution (Sigma-Aldrich, St. 
Louis, MO, USA) for 24 hours at 4°C. Then, a paraffin block was made, 
and 5 µm-thick sections were prepared for Masson’s trichrome st-
aining. Slides were deparaffinized and hydrated with distilled wa-
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ter. Hydrated samples were mordant in Bouin’s solution preheated 
to 58°C for 15 minutes. After cooling at room temperature, the sec-
tions were washed in running water until the yellow color disap-
peared and then rinsed in two changes of distilled water. Samples 
were then stained with modified Weigert’s iron hematoxylin for 5 
minutes, washed briefly in running water, and rinsed in two changes 
of distilled water. Slides were placed in 0.5% hydrochloric acid in 
70% alcohol for 5 seconds, washed in running tap water for 30 sec-
onds, and rinsed in two changes of distilled water. Biebrich scarlet-
acid fuchsin solution was used to treat the samples for 5 minutes. 
Slides were rinsed in three changes of distilled water and treated 
with phosphomolybdic-phosphotungstic acid solution for 5 min-
utes and aniline blue solution for 20 minutes. Finally, the samples 
were treated with acetic acid solution for 10 seconds, rinsed, dehy-
drated in alcohol, cleared in graded alcohols, and mounted with 
synthetic resin. The ratio of the purple fibrosis area to the total sur-
face area of each section was used to assess the degree of LA fibro-
sis (%) as (fibrosis are-total area)×100. 
Statistical analyses
Data were summarized as the mean±standard deviation for con-
tinuous variables and as frequency (percentage) for categorical va-
riables. We compared demographic variables and medically related 
variables between the MS and MR groups using Student’s t-test for 
continuous variables and Fisher’s exact test for categorical vari-
ables. Simple linear regression analyses and correlation analyses 
were performed to examine the relationships between each predic-
tor and LA reverse remodeling or LA fibrosis. Furthermore, a multi-
ple linear regression was performed to determine important predic-
tors of LA fibrosis and LA reverse remodeling. Clinical data variables 
such as age, rhythm, predominant disease, and operation method 
were included in the analysis. These variables were selected accord-
ing to their clinical relevance and potential impact on LA function, 
as shown in earlier studies.2) The inclusion p was <0.05, and the ex-
clusion p was >0.10. For estimating inter-observer variability and 
intra-observer variability, Pearson’s correlation was calculated and 
Bland-Altman analysis was performed. All analyses were performed 
using Statistical Package for the Social Sciences (SPSS) ver. 13.0 
(SPSS Inc., Chicago, IL, USA).
Results
Baseline characteristics
Baseline characteristics of the patients are summarized in Table 1. 
B  A  
C   D  
Fig. 1. Left atrial (LA) strain as measured by speckle tracking echocardiography and its corresponding histopathology. A case with higher LA global strain 
(29%) (A) and a lower degree of LA fibrosis (9%) (B). A case with lower LA global strain (6.9%) (C) and a correspondingly high degree of LA fibrosis (40%) 
(D). The dotted line represents the LA global strain, and the arrow indicates the peak longitudinal strain value. On these histology slides, the purple color 
represents fibrosis after Masson Trichrome staining (×20).
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Of the 50 patients, 28 and 22 underwent MV surgery due to pre-
dominant MS and predominant MR, respectively. Thirty-two pa-
tients (64%) had AF, with a higher prevalence found in the MS gr-
oup. Thirty-five patients (70%), mostly in the MS group, underwent 
MV replacement surgery and 15 patients underwent MV repair. Six-
teen patients (32%) underwent the Maze procedure or cryoabla-
tion for AF during surgery. 
Preoperative echocardiography and speckle tracking imaging 
Data on conventional echo-Doppler and 2D strain measurements 
before MV surgery are presented in Table 1. The mean LV ejection 
fraction was 58.3±10.9% and the global longitudinal LV strain of 
MS patients was significantly lower than that of MR patients, de-
spite similar LV ejection fractions. The mean LAVImax was 89.0± 
42.9 mL/m2, with no significant difference between the two groups. 
The mean LA global strain was 11.3±6.2%, with a higher value in MR 
patients than in MS patients (15.8±5.9% vs. 7.9±3.2%, p=0.002). 
The mean LA global systolic strain rate was 0.58±0.28 1/s. LA glo-
bal strain was significantly correlated with LAVImax (r=-0.403, p= 
0.005), LV global strain (r=-0.681, p<0.001), LA reservoir fraction (r= 
0.422, p=0.003) and LA global systolic strain rate (r=0.690, p=0.001). 
The regional strain value was higher in the basal and mid segments 
than the apical segements. Lateral, anterior, and inferior segment 
strain values were higher than septal strain values. Like global strain 
values, regional strain values were higher in the MR group compar-
ed to the MS group (Table 2). 
Degree of left atrial fibrosis and its correlates
The mean degree of LA fibrosis was 29.3±18.7%, with higher 
degrees in the MS group than in the MR group (36.5±20.4% vs. 
20.1±11.0%, p=0.001). Table 3 shows correlates of LA fibrosis. AF, 
MS rather than MR, rheumatic heart disease, LA reservoir fraction 
(r=-0.314, p=0.027), LA global strain (r=-0.546, p<0.001), and LA sys-
tolic global strain rate (r=-0.276, p<0.001) were significantly cor-
related with degree of LA fibrosis. But, LAVImax did not correlate 
with degree of fibrosis. Among 12 LA segments, mid-septal strain 
Table 1. Baseline clinical characteristics and echo-Doppler indices
Total (n=50) MS (n=28) MR (n=22) p
Age (years) 56±12 53±10 59±14 0.091
Female, n (%) 27 (54) 16 (57) 11 (50) 0.776
BSA (m2) 1.66±0.18 1.65±0.18 1.68±0.20 0.599
Serum creatinine (mg/dL) 1.1±0.8 1.2±1.0 1.0±0.2 0.473
DM, n (%) 9 (18) 4 (14) 5 (22) 0.460
Hypertension, n (%) 15 (30) 5 (18) 10 (45) 0.027
Atrial fibrillation, n (%) 32 (64) 21 (75) 11 (50) 0.083
Rheumatic heart disease, n (%) 32 (64) 28 (100) 4 (18) <0.001 
Medication, n (%)
ACE-inhibitors 10 (20) 3 (12) 7 (29) 0.101
ARB 9 (18) 3 (12) 6 (25) 0.137
Diuretics 27 (54) 14 (54) 13 (59) 0.371
Beta-blockers 7 (14) 3 (12) 4 (18) 0.390
Calcium channel blockers 5 (10) 2 (8) 3 (14) 0.399
MV replacement, n (%) 35 (70) 28 (100) 7 (32) <0.001
Maze procedure or cryoablation, n (%) 16 (32) 10 (36) 6 (27) 0.559
LV end-diastolic dimension (mm) 55.2±8.3 51.3±7.2 60.2±7.9 <0.001
LV ejection fraction (%) 58.3±10.9 56.2±9.2 61.0±12.3  0.126
LV global strain (%) -14.5±4.8 -12.4±4.1 -16.7±4.7  0.002
LA volume index (mL/m2) 89.0±42.9 89.6±31.2 87.8±54.7  0.871
LA reservoir fraction 0.36±0.24 0.28±0.19 0.46±0.27 0.009
LA global strain (%) 11.3±6.2 7.9±3.2 15.8±5.9  0.002
LA global systolic strain rate (/sec) 0.58±0.28 0.41±0.17 0.75±0.27 <0.001
Degree of LA fibrosis (%) 29.3±18.7 36.5±20.4 20.1±11.0 0.001
Data are summarized as means±SD for continuous variables and as frequency (%) for categorical variables. MS: mitral stenosis, MR: mitral regurgitation, 
BSA: body surface area, DM: diabetes mellitus, ACE: angiotensin converting enzyme, ARB: angiotensin receptor blocker, MV: mitral valve, LV: left ventricular, 
LA: left atrial
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correlated best with the degree of fibrosis (r=-0.510, p<0.001). How-
ever, preoperative LAVImax and the LV global strain did not corre-
late with the degree of LA fibrosis. In multivariate analysis, the de-
gree of LA fibrosis was significantly correlated with the LA global 
strain even after adjustment for age, underlying rhythm, rheumatic 
heart disease, and predominant disease. In subgroup analysis ac-
cording to predominant disease, LA global strain was better corre-
lated with degree of LA fibrosis in patients with predominant MS 
than in subjects as a whole (r=-0.639, p<0.001) (Fig. 2). However, 
LAVImax did not correlate with the degree of fibrosis. In MR-pre-
dominant patients, LA global strain was not significantly correlated 
with degree of fibrosis (r=-0.370, p=0.099). In subgroup AF and si-
nus rhythm subgroups, LA global strain correlated with degree of 
fibrosis but degree of correlation was not significantly different due 
to small sample size (Table 4). 
Determinants of left atrial reverse remodeling after mitral 
valve surgery
Mean LAVImax decreased by 61.7±31.7 mL/m2 (immediate after 
surgery) and 50.7±20.7 mL/m2 (1-year follow-up; 55±12 years, 21 
MS patients). The mean percent change in LAVImax was 29.4± 
14.8% and 36.6±16.6%, respectively. The degree of LA fibrosis was 
significantly correlated with percent LA volume reduction after MV 
surgery (r=-0.337, p=0.017 immediately after surgery; r=-0.477, p= 
0.002 1-year later). Table 4 and 5 shows the correlations between 
preoperative echocardiographic measurements and degree of LA 
volume reduction after MV surgery. LA reservoir fraction was related 
Table 2. Segmental left atrial strain values
Total MS MR p*
Basal septum 13.0±12.8 8.5±8.7 19.2±15.0 0.004
Mid septum 13.0±11.5 9.3±8.3 17.9±13.5 0.012
Apical septum 12.1±13.7 9.3±12.5 14.8±3.4 0.017
Basal lateral 18.5±14.8 12.9±12.0 26.2±15.2 0.002
Mid lateral 11.7±12.1 10.3±12.2 13.5±12.0 0.386
Apical lateral 3.5±7.7 1.8±6.8 5.9±8.4 0.080
Basal anterior 18.8±21.0 13.4±13.7 25.4±26.5 0.080
Mid anterior 13.3±14.8 7.2±12.8 20.9±13.8 0.003
Apical anterior 2.2±19.1 0.5±12.0 4.3±25.7 0.559
Basal inferior 21.0±26.1 10.3±6.9 34.2±34.3 0.004
Mid inferior 17.9±19.6 12.7±10.0 24.4±26.1 0.066
Apical inferior -1.2±10.3 1.8±9.3 -4.9±10.7 0.045
All the values are presented as %. *Comparison between MS and MR. MS: 
mitral stenosis, MR: mitral regurgitation
Table 3. Correlates for degree of LA fibrosis
Univariate analysis Multivariate analysis
R p B (95% CI) p
Age 0.535 0.089 0.28 (-0.11 - 0.66) 0.155
Rhythm (sinus rhythm=0, AF=1) 0.316 0.025 -4.19 (-16.91 - 8.53) 0.510
Predominant disease (MS=0, MR=1) -0.440 0.001 -13.06 (-29.87 - 3.75) 0.125
Rheumatic heart disease 0.417 0.003 4.25 (-14.40 - 22.90) 0.648
LV ejection fraction 0.024 0.870
LV global strain 0.157 0.332
LA volume index 0.167 0.246
LA global strain -0.546 <0.001 -1.37 (-2.32 - -0.41) 0.006
LA reservoir fraction* -0.314 0.027
LA global systolic strain rate* -0.276  <0.001
*LA global systolic strain rate and LA reservoir fraction were not included in multivariable analysis due to significant colinearity with LA global strain. CI: 
confidence interval, AF: atrial fibrillation, MS: mitral stenosis, MR: mitral regurgitation, LV: left ventricular, LA: left atrial 
Table 4. Determinants of LA fibrosis and postoperative LA volume reduction according to baseline rhythm
Degree of fibrosis Immediately after surgery 1-year after surgery 
NSR (n=18) AF (n=32) NSR (n=18) AF (n=32)  NSR  (n=15) AF (n=24)
LV global strain 0.24* (0.36) 0.09 (0.64) -0.02 (0.94) -0.14 (0.46) 0.29 (0.34) -0.18 (0.40)
LA reservoir fraction -0.34 (0.17) -0.14 (0.45) 0.45 (0.07) 0.38 (0.03) -0.02 (0.95) 0.04 (0.98)
LA global strain -0.49 (0.04) -0.39 (0.03) 0.34 (0.20) 0.20 (0.30) 0.48 (0.09) 0.13 (0.31)
LA global systolic strain rate -0.26 (0.15) -0.15 (0.09) 0.08 (0.79) 0.18 (0.34) 0.16 (0.62) 0.22 (0.32)
LA fibrosis -0.38 (0.12) -0.25 (0.17) -0.68 (0.006) -0.27 (0.21)
*Correlation coefficient (p). NSR: normal sinus rhythm, AF: atrial fibrillation, LV: left ventricular, LA: left atrial
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to with percent LA volume reduction immediately after MV surgery 
(r=0.449, p=0.001) but LA global strain failed to reach significance 
(r=0.258, p=0.074). 
In multivariate analysis, after adjusting for underlying rhythm, 
the degree of LA fibrosis was significantly related to percent LA vo-
lume reduction after MV surgery (regression coefficient, B=-0.002, 
95% CI -0.004-0.000, p=0.027). However, LA global strain (r=0.272, 
p=0.112) and reservoir fraction (r=0.118, p=0.301) did not signifi-
cantly correlate with percent LA volume reduction at the 1-year fol-
low-up. 
Reproducibility of two-dimensional speckle tracking imaging 
Interobserver variability coefficients of LA global strain and glo-
bal strain rate were 95% CI±1.8; percent error 5.3% and 95% CI± 
2.4; percent error 8.2%, respectively using Bland-Altman analysis. 
In intraobserver variability assessment, coefficients of LA global 
strain and global strain rate were 95% CI±1.7; percent error 3.2% 
and 95% CI±1.6; percent error 6.8%, respectively. Bland-Altman 
analysis showed no evidence of any systematic difference regard-
ing interobserver and intraobserver variability. 
Discussion
The major finding of this study is that LA global strain measured 
by speckle tracking imaging was reproducible and was significantly 
correlated with the degree of LA fibrosis in patients with MV dis-
ease. The strain curve evaluated by speckle tracking imaging closely 
follows LA physiology. During the period of the LA reservoir, the LA 
strain increases, reaching its peak at the end of LA filling from the 
pulmonary venous inflow, just before the MV opening.13)14) During 
the conduit phase, the LA strain decreases, showing a plateau dur-
ing diastasis, and achieves a negative peak at the end of LA contrac-
tion. LA global strain is a positive strain during ventricular systole, 
but not during atrial systole, so a positive global LA strain represents 
LA stretching during ventricular systole. In this study, we focused 
on peak positive global LA strain and systolic strain rate as an index 
of LA reservoir function because it is an important determinant of 
LA stiffness, preload of LA, and pulmonary venous pressure in MV 
disease.15-17) Even in patients with AF, which is frequently encoun-
tered in MV disease, these reservoir functional indices could be re-
liably measured. This finding suggests that LA global strain can be 
used as an index of LA compliance or reservoir function. We also 
Fig. 2. Correlation between LA global strain and degree of LA fibrosis (A) and its subgroup analysis according to predominant mitral valve disease (B). Cor-
relation of percent LA volume reduction after surgery with degree of LA fibrosis (C) and LA global strain (D). LA: left atrial, MS: mitral stenosis, MR: mitral 
regurgitation.
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confirmed the significant correlation of the LA global strain value 
with LA reservoir fraction derived from LA volume change.18) Con-
sidering the limitations of other methods for assessment of LA 
function,19) assessments of the LA strain and strain rate by speckle 
tracking imaging may represent a relatively rapid and easy-to-per-
form technique to explore LA function.20) This approach may be of 
potential clinical importance in a number of pathophysiologic con-
ditions typically associated with abnormal LA function, such as MS 
or MR and cardiomyopathies. 
LA compliance, like diastolic stiffness of LV, might be related to 
the degree of interstitial fibrosis, although the evident to date has 
been scant. Presently, LA expansion or peak lengthening strain dur-
ing ventricular systole, represented by positive strain, was signifi-
cantly correlated with the degree of LA interstitial fibrosis. The st-
rength of this study is that we could confirm that the degree of LA 
fibrosis was significantly correlated with the preoperative LA global 
strain and early strain rate as representatives of reservoir function. 
The reservoir fraction from LA volume change was also correlated 
with degree of fibrosis, but was not superior to the global LA strain 
and took more time to measure. This finding is consistent with pre-
vious findings that LA strain rather, than reservoir fraction, better 
predicts AF recurrence after cardioversion.15) Unlike the LA strain, pre-
operative LAVImax did not correlate with LA fibrosis in our study, 
suggesting that, although LA volume has been used as a reliable in-
dex for prognostication as a representative of long-term LV diastolic 
function, it is insufficient to provide mechanistic information about 
the left atrium itself. The applicability of LA volume in various dis-
ease entities still has some limitations. Therefore, combining LA vol-
ume with function by strain might provide better information in 
terms of atrial-ventricular coupling. It is also interesting that, al-
though LA strain is significantly correlated with degree of LA fibro-
sis independent of predominant disease, the degree of correlation 
was far better in the MS group. 
Although we could confirm that degree of LA fibrosis is related 
to degree of LA volume reduction after MV surgery, we could not 
find significant correlation between LA strain and LA volume re-
duction in spite of positive tendency. Therefore factors other than 
LA fibrosis, such as LV diastolic function, LV remodeling, operation 
method or concomitant AF surgery, might also significantly affect 
reverse remodeling of LA. 
Study limitations
In our study, some limitations existed. First, since this study en-
rolled a relatively small number of patients with heterogeneous 
characteristics, additional recruitment of pure MR patients would 
be helpful to confirm the relationship within pure MR group. Our re-
sults still cannot be generalized to other disease entities other than 
MS. The observation that fibrosis was significantly higher in the MS 
group, rather than the MR group, might reflect a ehigher rheumatic 
involvement in the MS group and higher angiotension converting 
enzyme inhibitor or angiotensin receptor blocker use in MR patients. 
Likewise, as we had limited long-term follow-up data, larger scaled 
long-term follow-up studies would be helpful to achieve the sta-
tistical power necessary to ascertain the predictive value of LA strain 
for LA reverse remodeling. Second, consideration should be given 
to the difficulty in obtaining an accurate ROI close enough to the 
effective shape of the left atrium and to the risk of contamination by 
signal components arising from structures surrounding the left atri-
um. Higher frame rate using zoom mode might have provided a bet-
ter quality of speckle tracking. Also, because there is no software spe-
cifically developed for LA strain analysis, we used software for LV 
analysis to assess the LA strain and strain rate. Third, only longitu-
dinal function variables were evaluated in this study. The LA radial 
strain could not be calculated from apical four- and two-chamber 
views because the atrial wall was too thin to track the acoustic ker-
nels associated with radial movement of the thin LA wall. Fourth, 
the strain rate value was not included in the segmental analysis as 
regional strain rate curve was too noisy to analyze properly.
In conclusion, 2D speckle tracking strain echocardiography rep-
resents a promising and reproducible non-invasive technique for 
assessing LA reservoir function in patients with MV disease. Analy-
Table 5. Determinants of postoperative percent LA volume reduction 
Immediately  
after surgery (n=50)
1-year after 
surgery (n=39)
R p  R p
Age -0.026 0.860 -0.259 0.111
Rhythm 
  (sinus rhythm=0, AF=1)
-0.238 0.056 -0.010 0.949
Predominant disease
  (MS=0, MR=1)
0.129 0.197 0.055 0.739
Method of operation 
  (MVR=0, Repair=1)
0.103 0.248 0.209 0.201
Rheumatic heart disease
  (nonRHD=0, RHD=1)
0.144 0.322 -0.185 0.259
AF surgery 0.039 0.790 0.048 0.770
LV ejection fraction 0.107 0.507 -0.031 0.853
LV global strain 0.112 0.504 -0.063 0.715
LA reservoir fraction 0.449 0.001 0.118 0.301
LA global strain 0.258 0.074 0.272 0.113
LA global systolic 
  strain rate
0.094 0.603 0.028 0.871
LA fibrosis -0.337 0.017 -0.477 0.002
AF: atrial fibrillation, MS: mitral stenosis, MR: mitral regurgitation, MVR: mitral 
valve replacement, RHD: rheumatic heart disease, LV: left ventricular, LA: 
left atrial
318 Left Atrial Strain and Left Atrial Fibrosis
http://dx.doi.org/10.4070/kcj.2012.42.5.311 www.e-kcj.org
ses of strain and strain rate of the left atrium might provide infor-
mation regarding degree of LA fibrosis in patients with severe MV 
disease, especially in MS patients. 
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